Works matching DE "INTEGRASE inhibitors"
Results: 429
Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase.
- Published in:
- PLoS Biology, 2016, v. 14, n. 12, p. 1, doi. 10.1371/journal.pbio.1002584
- By:
- Publication type:
- Article
Rapid activity prediction of HIV-1 integrase inhibitors: harnessing docking energetic components for empirical scoring by chemometric and artificial neural network approaches.
- Published in:
- Journal of Computer-Aided Molecular Design, 2016, v. 30, n. 6, p. 471, doi. 10.1007/s10822-016-9917-0
- By:
- Publication type:
- Article
Virtual screening of integrase inhibitors by large scale binding free energy calculations: the SAMPL4 challenge.
- Published in:
- Journal of Computer-Aided Molecular Design, 2014, v. 28, n. 4, p. 475, doi. 10.1007/s10822-014-9711-9
- By:
- Publication type:
- Article
Exhaustive docking and solvated interaction energy scoring: lessons learned from the SAMPL4 challenge.
- Published in:
- Journal of Computer-Aided Molecular Design, 2014, v. 28, n. 4, p. 417, doi. 10.1007/s10822-014-9715-5
- By:
- Publication type:
- Article
High incidence of delayed graft function in HIV-infected kidney transplant recipients.
- Published in:
- Transplant International, 2013, v. 26, n. 9, p. 893, doi. 10.1111/tri.12147
- By:
- Publication type:
- Article
Integration-induced death.
- Published in:
- Nature Immunology, 2013, v. 14, n. 8, p. 776, doi. 10.1038/ni.2673
- By:
- Publication type:
- Article
Replicative co-infections with human immunodeficiency virus 1 and 2 as well as hepatitis B and C virus in Ghanaian individuals.
- Published in:
- European Journal of Microbiology & Immunology, 2024, v. 14, n. 4, p. 346, doi. 10.1556/1886.2024.00103
- By:
- Publication type:
- Article
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 1, p. 130, doi. 10.3390/biom14010130
- By:
- Publication type:
- Article
The safety and efficacy of PD-1 inhibitors in patients with advanced cancers and HIV/AIDS in China.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1248790
- By:
- Publication type:
- Article
Natural killer cells induce HIV-1 latency reversal after treatment with pan-caspase inhibitors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1067767
- By:
- Publication type:
- Article
Primary and secondary resistance of HIV-1 to integrase inhibitors in Cuban patients infected with multidrug-resistant HIV strains.
- Published in:
- Journal of Microbiology & Infectious Diseases, 2023, v. 13, n. 2, p. 72, doi. 10.5455/JMID.2023.v13.i2.4
- By:
- Publication type:
- Article
Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36330-5
- By:
- Publication type:
- Article
Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36330-5
- By:
- Publication type:
- Article
Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32554-z
- By:
- Publication type:
- Article
HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2021, v. 20, n. 2, p. 333, doi. 10.22037/ijpr.2021.115446.15370
- By:
- Publication type:
- Article
Latest advances in the efficacy, tolerability, and monotherapy of integrase inhibitors.
- Published in:
- BioScience Trends, 2017, v. 11, n. 4, p. 490, doi. 10.5582/bst.2017.01194
- By:
- Publication type:
- Article
Clinical considerations when switching antiretroviral therapy.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 7, p. 565, doi. 10.1080/17512433.2024.2365826
- By:
- Publication type:
- Article
The clinical pharmacology of integrase inhibitors.
- Published in:
- Expert Review of Clinical Pharmacology, 2019, v. 12, n. 1, p. 31, doi. 10.1080/17512433.2019.1553615
- By:
- Publication type:
- Article
Prevalence, treatment, and factors associated with cryptococcal meningitis post introduction of integrase inhibitors antiretroviral based regimens among People Living with HIV in Tanzania.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0294940
- By:
- Publication type:
- Article
Nucleoside Reverse Transcriptase Inhibitors Are the Major Class of HIV Antiretroviral Therapeutics That Induce Neuropathic Pain in Mice.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 9059, doi. 10.3390/ijms25169059
- By:
- Publication type:
- Article
Recent Developments in the Synthesis of HIV-1 Integrase Strand Transfer Inhibitors Incorporating Pyridine Moiety.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 11, p. 9314, doi. 10.3390/ijms24119314
- By:
- Publication type:
- Article
Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds.
- Published in:
- 2023
- By:
- Publication type:
- Literature Review
High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14300, doi. 10.3390/ijms232214300
- By:
- Publication type:
- Article
Antiproliferative Effects of the Aptamer d(GGGT) 4 and Its Analogues with an Abasic-Site Mimic Loop on Different Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 5952, doi. 10.3390/ijms23115952
- By:
- Publication type:
- Article
Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Enzyme Inhibitors: The Best Strategy to Tackle Superbug NDM-1 and Its Variants.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 1, p. 197, doi. 10.3390/ijms23010197
- By:
- Publication type:
- Article
Variability in HIV-1 Integrase Gene and 3′-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 5, p. 1553, doi. 10.3390/ijms21051553
- By:
- Publication type:
- Article
Cabotegravir.
- Published in:
- Australian Prescriber, 2022, v. 45, n. 4, p. 134, doi. 10.18773/austprescr.2022.039
- Publication type:
- Article
Bictegravir/emtricitabine/tenofovir alafenamide.
- Published in:
- Australian Prescriber, 2019, v. 42, n. 2, p. 68, doi. 10.18773/austprescr.2019.016
- Publication type:
- Article
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Explaining the Determinants of First Phase HIV Decay Dynamics through the Effects of Stage-dependent Drug Action.
- Published in:
- PLoS Computational Biology, 2013, v. 9, n. 3, p. 1, doi. 10.1371/journal.pcbi.1002971
- By:
- Publication type:
- Article
Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV‐1 infected patients in 2020–2023.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 10, p. 1, doi. 10.1002/jmv.29948
- By:
- Publication type:
- Article
Rheumatic diseases in HIV-infected patients in the post-antiretroviral therapy era: a tertiary care center experience.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 1, p. 71, doi. 10.1007/s10067-018-4089-z
- By:
- Publication type:
- Article
Rapid viral suppression using integrase inhibitors during acute HIV-1 infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 1, p. 169, doi. 10.1093/jac/dkae391
- By:
- Publication type:
- Article
Correction to: Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 6, p. 1471, doi. 10.1093/jac/dkae131
- Publication type:
- Article
Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 5, p. 1157, doi. 10.1093/jac/dkae086
- By:
- Publication type:
- Article
Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 2, p. 287, doi. 10.1093/jac/dkad375
- By:
- Publication type:
- Article
Are unknown co-medications, over-the-counter and off-label drug use still problems among people living with HIV? Results from a transversal survey in 23 centres in France.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 11, p. 2731, doi. 10.1093/jac/dkad292
- By:
- Publication type:
- Article
Oestradiol concentrations in trans women with HIV suppressed on unboosted integrase inhibitor regimens versus trans women without HIV taking oral oestradiol: a pilot study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 11, p. 2653, doi. 10.1093/jac/dkad270
- By:
- Publication type:
- Article
Association of depression and suicidal behaviour reporting with HIV integrase inhibitors: a global pharmacovigilance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 8, p. 1944, doi. 10.1093/jac/dkad187
- By:
- Publication type:
- Article
Transmission of S230R integrase drug resistance mutation affecting second-generation integrase inhibitors in a French primary HIV-1 infected man.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 7, p. 1802, doi. 10.1093/jac/dkad135
- By:
- Publication type:
- Article
Long-term treatment outcome and mutational analysis of patients on third-line antiretroviral therapy in programmatic conditions.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 6, p. 1480, doi. 10.1093/jac/dkad111
- By:
- Publication type:
- Article
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 6, p. 1415, doi. 10.1093/jac/dkad101
- By:
- Publication type:
- Article
Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 5, p. 1314, doi. 10.1093/jac/dkad109
- By:
- Publication type:
- Article
Primary resistance to integrase inhibitors in Shenzhen.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 2, p. 546, doi. 10.1093/jac/dkac442
- By:
- Publication type:
- Article
HIV-1 resistance genotyping by ultra-deep sequencing and 6-month virological response to first-line treatment.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 2, p. 346, doi. 10.1093/jac/dkac391
- By:
- Publication type:
- Article
HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetics of vaginally applied integrase inhibitors in macaques.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohort.
- Published in:
- 2021
- By:
- Publication type:
- journal article